Balance Training in Diabetic Neuropathy

August 18, 2021 updated by: Rabeiya Tazeem, Dow University of Health Sciences

Efficacy of Balance Training in Comparison to General Exercises Alone in Diabetic Neuropathy

This study evaluates the efficacy of balance training in Diabetic Neuropathy. Control group will receive general exercises while Eperimental/ Interventional group will receive Balance exercises along with general exercises.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan, 74200
        • Institute of physical medicine and rehabilitation, Dow University of health sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age group: 30-60 years
  • Diabetes type II patients diagnosed with peripheral neuropathy by medical doctor for at least 5 years
  • Neuropathy present (on the basis of Michigan Neuropathy Screening Instrument
  • Have balance impairment ( evaluation on Berg Balance Scale)

Exclusion Criteria:

  • Neuropathy due to other medical conditions like Vitamin deficiency, Hypothyroidism, Auto-immune/ demyelinating diseases
  • Foot ulcers
  • Lower limb amputee
  • Vestibular diseases
  • Retinopathy
  • Cardiac problems
  • Hemiplegia/ Stroke

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Experimental Group

Balance training by 9 positions with 1 min hold, repeated twice

  1. Stand with feet together, eyes remain open
  2. Stand with together, eyes closed
  3. & 4) Tandem Standing with Right and Left in front alternately

5) Forward Reaching 6) & 7) Single Leg Standing, with Right and Left foot alternately 8) & 9) Step up, with Right and Left foot alternately

General Exercises for 25 min

  • Active Range of Motion Exercises and Foot Care Education-5 min
  • Treadmill- 15 min
  • Cycling -5 min

No. Of Sessions 24, thrice a week for 8 weeks

Balance enhancing exercises
General Exercises
ACTIVE_COMPARATOR: Control Group

General Exercises for 25 min

  • Active Range of Motion Exercises and Foot Care Education-5 min
  • Treadmill- 15 min
  • Cycling -5 min

No. Of Sessions 24, thrice a week for 8 weeks

General Exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Scale
Time Frame: Baseline (Pre treatment)
The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks. Katherine Berg developed this test to assess the level of function and balance in various patient populations. Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)
Baseline (Pre treatment)
Berg Balance Scale
Time Frame: At 4th week of treatment
The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks. Katherine Berg developed this test to assess the level of function and balance in various patient populations. Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)
At 4th week of treatment
Berg Balance Scale
Time Frame: At 8th week of treatment (Post treatment )
The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks. Katherine Berg developed this test to assess the level of function and balance in various patient populations. Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)
At 8th week of treatment (Post treatment )

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 12, 2019

Primary Completion (ACTUAL)

September 1, 2020

Study Completion (ACTUAL)

November 1, 2020

Study Registration Dates

First Submitted

January 11, 2020

First Submitted That Met QC Criteria

January 15, 2020

First Posted (ACTUAL)

January 18, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 19, 2021

Last Update Submitted That Met QC Criteria

August 18, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetic Neuropathy With Neurologic Complication

Clinical Trials on Balance Training

3
Subscribe